Brexpiprazole D8 is the octa-deuterated form (in the piperazine ring) of Brexpiprazole (OPC34712; Rexulti; OPC-34712), which is a novel D2 dopamine partial agonist [serotonin-dopamine activity modulator (SDAM)] used for the treatment of schizophrenia, and as an adjunctive treatment for depression.

纯度：≥98%

CAS：1427049-21-5